Our Board of Directors are built to help guide our vision, bringing extensive experience in clinical drug development with a keen perspective on emerging technologies, next generation analytics and the application of precision medicine. Click to expand.

Vern Davenport is Partner at NovaQuest Capital Management and has more than 35 years experience of building and transforming healthcare technology and services companies. He is Investment Committee Member at NovaQuest Private Equity.

Before NovaQuest, Vern was CEO and Board Member at Medfusion. Previously, Vern was Chairman and CEO of Medquist before and after the privatization of the company. He rebranded the company to M*Modal and led the take private process, resulting in the sale to One Equity Partners.

Vern’s experience includes President, Allscripts; CEO, Misys Healthcare; GM & EVP, Kodak Health Group (now Carestream Health) and executive leadership roles at Siemens and Shared Medical Systems. He also was at IBM for 11 years, serving in sales leadership and executive management positions. 

Vern received an MBA and a BSBA in Business from East Carolina University.  He serves on the East Carolina Board of Trustees and the WakeMed Health and Hospitals Boards and has held other board positions.

Nick Dyer is the CEO of Catalyst Clinical Research, LLC and has more than 21 years experience in healthcare and life sciences.  Previously, Nick was President of Novella Clinical and also served as Chief Commercial Officer.  At Novella, Nick fervently embraced the need for therapeutically-focused CRO solutions interlaced with a flexible, small biotech, customer service model.  Nick also led clinical operations, finance, IT, and sales/marketing functions for Quintiles (IQVIA) and Pharmaceutical Product Development.  Previously, Nick led a finance group for a large UK based hospital following a three-year postgraduate healthcare management program with the UK National Health Service.

Nick received a First Class Bachelor’s Degree in Economics from the University of Greenwich, London and qualified as a Chartered Public Finance Accountant in 1995.

Jeff Edwards has over 18 years of investment experience and is a Partner at NovaQuest Capital Management. He is responsible for transaction origination, investment policy, fundraising, and the day-to-day management of NovaQuest Capital Management. In addition, he directs the Private Equity team in acquisitions, divestitures, and oversight of portfolio companies.

Prior to joining NovaQuest, Jeff co-led the Principal Investment Private Equity program at the Teacher Retirement System of Texas, leading the efforts in the Healthcare and Industrial sectors across a variety of geographies. In that role, he was responsible for making investment decisions, deal origination, as well as portfolio construction and portfolio management.

Jeff’s previous experience also includes M&A advisory work for Raymond James Capital Markets, focusing on middle-market companies. He also worked for State Street Global Markets (SSGM). His efforts were focused on private equity fund formation, portfolio management, and investment due diligence. Before moving back to the capital markets sector, Jeff worked in finance and administrative roles in the healthcare industry with Carolinas HealthCare Systems and HCA, Inc. He started his career with the middle market investment bank RW Baird.

Jeff received an MBA from the University of North Carolina at Chapel Hill, an MSF from Boston College, and a BA from the University of Tennessee at Knoxville. He is also a CAIA Charter Holder.